Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy.
apoptosis
cancer
radio-resistance
radio-sensitivity
radiopharmaceuticals
Journal
Dose-response : a publication of International Hormesis Society
ISSN: 1559-3258
Titre abrégé: Dose Response
Pays: United States
ID NLM: 101308899
Informations de publication
Date de publication:
Historique:
received:
17
09
2020
revised:
15
01
2021
accepted:
17
01
2021
entrez:
15
3
2021
pubmed:
16
3
2021
medline:
16
3
2021
Statut:
epublish
Résumé
The rapid advances in nuclear medicine have resulted in significant advantages for the field of oncology. The focus is on the application of radiopharmaceuticals as therapeuticals. In addition, the latest developments in cell biology (the understanding of the cell structure, function, metabolism, genetics, signaling, transformation) have given a strong scientific boost to radiation oncology. In this regard, the article discusses what is soon going to be a new jump in radiation oncology based on the already accumulated considerable knowledge at the cellular level about the mechanisms of cell transformation and tumor progression, cell response to radiation, cell resistance to apoptosis and radiation and cell radio-sensitivity. The mechanisms of resistance of tumor cells to radiation and the genetically determined individual sensitivity to radiation in patients (which creates the risk of radiation-induced acute and late side effects) are the 2 major challenges to overcome in modern nuclear medicine. The paper focuses on these problems and makes a detailed summary of the significance of the differences in the ionizing properties of radiopharmaceuticals and the principle of their application in radiation oncology that will shed additional light on how to make the anti-cancer radiotherapies more efficient and safe, giving some ideas for optimizations.
Identifiants
pubmed: 33716590
doi: 10.1177/1559325821993665
pii: 10.1177_1559325821993665
pmc: PMC7923993
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1559325821993665Informations de copyright
© The Author(s) 2021.
Déclaration de conflit d'intérêts
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Int J Oncol. 2014 Nov;45(5):1813-9
pubmed: 25174607
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
J Am Coll Nutr. 2006 Apr;25(2):79-99
pubmed: 16582024
Oncol Lett. 2017 Dec;14(6):7011-7015
pubmed: 29344129
Microbiol Mol Biol Rev. 2011 Mar;75(1):133-91
pubmed: 21372322
Nature. 2016 Oct 20;538(7625):378-382
pubmed: 27732578
Dose Response. 2018 Jul 08;16(3):1559325818784719
pubmed: 30013458
Complement Med Res. 2018;25(2):102-113
pubmed: 29130953
Cold Spring Harb Perspect Biol. 2012 Dec 01;4(12):
pubmed: 23209155
Tumour Biol. 2017 Mar;39(3):1010428317695010
pubmed: 28345453
J Nutr Biochem. 2006 Feb;17(2):89-95
pubmed: 16111881
Mol Aspects Med. 2010 Feb;31(1):29-59
pubmed: 20026172
Cancer Lett. 2015 Jan 28;356(2 Pt A):165-70
pubmed: 24486219
Hepatology. 2005 May;41(5):1074-84
pubmed: 15841469
J Neurochem. 1999 Mar;72(3):933-42
pubmed: 10037464
J Bioenerg Biomembr. 2009 Apr;41(2):169-80
pubmed: 19377835
J Cell Biochem. 2008 Jul 1;104(4):1124-49
pubmed: 18459149
J Lipid Res. 2019 Jan;60(1):30-43
pubmed: 30413652
J Biol Chem. 2003 Jun 13;278(24):22136-43
pubmed: 12672807
Cancer J. 2013 May-Jun;19(3):200-7
pubmed: 23708066
Int J Mol Med. 2012 Nov;30(5):1194-202
pubmed: 22948173
Stem Cells Int. 2012;2012:579104
pubmed: 22966236
Oncoscience. 2014 Aug 21;1(8):513-521
pubmed: 25594058
Clinics (Sao Paulo). 2018 Dec 10;73(suppl 1):e814s
pubmed: 30540126
Food Chem Toxicol. 1999 Sep-Oct;37(9-10):949-62
pubmed: 10541450
Nutrients. 2013 Feb 07;5(2):525-42
pubmed: 23434907
Cancer Cell. 2006 Jul;10(1):51-64
pubmed: 16843265
Cancer Treat Rev. 2008 Dec;34(8):737-49
pubmed: 18722718
Antioxidants (Basel). 2017 Nov 03;6(4):
pubmed: 29099803
J Cancer Res Ther. 2020 Dec;16(Supplement):S59-S63
pubmed: 33380653
J Exp Clin Cancer Res. 2019 May 22;38(1):209
pubmed: 31113478
Sci Rep. 2017 Sep 20;7(1):11923
pubmed: 28931851
Free Radic Biol Med. 2010 Dec 15;49(12):1846-55
pubmed: 20826207
Semin Cancer Biol. 2015 Dec;35 Suppl:S25-S54
pubmed: 25892662
Mol Cell Biol. 1998 Nov;18(11):6719-28
pubmed: 9774685
J Microsc. 1982 Oct;128(Pt 1):7-21
pubmed: 7143438
Cancers (Basel). 2017 Oct 27;9(11):
pubmed: 29077012
Free Radic Biol Med. 1999 Dec;27(11-12):1197-202
pubmed: 10641711
Mol Nutr Food Res. 2013 Jan;57(1):114-25
pubmed: 23293044
J Radiat Res. 2017 Nov 1;58(6):887-893
pubmed: 28992350
Oncotarget. 2016 Mar 8;7(10):11002-17
pubmed: 26716904
Int J Oncol. 2013 Nov;43(5):1495-502
pubmed: 23970333
Int J Radiat Biol. 2009 Jun;85(6):467-82
pubmed: 19401906
J Nucleic Acids. 2010 Oct 14;2010:179594
pubmed: 20981145
Clin Transl Radiat Oncol. 2017 Feb 17;2:63-68
pubmed: 29658003
Free Radic Biol Med. 2017 Jan;102:122-132
pubmed: 27890641
Biochim Biophys Acta. 2012 Jul;1819(7):743-56
pubmed: 22430255
Bioelectrochemistry. 2011 Aug;82(1):69-73
pubmed: 21632287
Dose Response. 2006 Aug 25;5(1):63-75
pubmed: 18648557
Carcinogenesis. 2003 Mar;24(3):511-5
pubmed: 12663512
Exp Mol Med. 2008 Feb 29;40(1):118-29
pubmed: 18305405
Antioxid Redox Signal. 2014 Jul 10;21(2):260-92
pubmed: 24382094
Front Oncol. 2017 Jun 15;7:128
pubmed: 28674677
Annu Rev Biochem. 2006;75:137-63
pubmed: 16756488
Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):776-784
pubmed: 29413288
Cancer Res. 2001 Dec 1;61(23):8578-85
pubmed: 11731445
Free Radic Biol Med. 2012 Jul 15;53(2):260-70
pubmed: 22580337
EBioMedicine. 2018 Apr;30:14-28
pubmed: 29526577
Dose Response. 2018 Jan 22;16(1):1559325817747387
pubmed: 29383010
Int J Radiat Biol. 2005 Feb;81(2):125-38
pubmed: 16019922
Free Radic Res. 2016 Nov;50(sup1):S64-S78
pubmed: 27593437
J Biol Chem. 1999 Aug 13;274(33):22932-40
pubmed: 10438458
Contemp Oncol (Pozn). 2012;16(5):394-400
pubmed: 23788916
EMBO J. 2000 Feb 1;19(3):463-71
pubmed: 10654944
J Biomed Sci. 2020 May 5;27(1):58
pubmed: 32370764
J Exp Med. 1994 Aug 1;180(2):525-35
pubmed: 8046331
J Clin Invest. 2013 Oct;123(10):4344-58
pubmed: 24091326
Radiat Res. 2016 Feb;185(2):190-8
pubmed: 26789702
Radiat Res. 2006 Mar;165(3):337-42
pubmed: 16494522
Oncogene. 2003 Nov 27;22(54):8645-52
pubmed: 14647458
Nucleic Acids Res. 2007;35(5):e36
pubmed: 17284459
Asian Pac J Trop Biomed. 2011 Jan;1(1):57-63
pubmed: 23569726
J Biol Chem. 2001 Nov 9;276(45):42462-7
pubmed: 11571274
Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8984-9
pubmed: 15956203
Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a001222
pubmed: 20463003
Phys Med Biol. 2013 Oct 21;58(20):7143-57
pubmed: 24052159
Front Mol Biosci. 2014 Nov 17;1:24
pubmed: 25988165